| # | AID | Title | Application | Method | Tested | Active | Status |
|---|---|---|---|---|---|---|---|
| 1 | 362 | Formylpeptide Receptor Ligand Binding Assay | NA | Screening | 4282 | 61 | Completed |
| 2 | 440 | Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands | 1R03MH076381-01 | Screening | 24304 | 181 | Completed |
| 3 | 441 | Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands | 1R03MH076381-01 | Screening | 24304 | 72 | Completed |
| 4 | 519 | Dose Response Assay for Formylpeptide Receptor (FPR) Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands | 1R03MH076381-01 | Confirmatory | 272 | 24 | Completed |
| 5 | 520 | Dose Response Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Dose Response Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands | 1R03MH076381-01 | Confirmatory | 272 | 6 | Completed |
| 6 | 698 | Secondary Calcium Response Assay for Formylpeptide Receptor-Like-1 (FPRL1) Antagonists | 1R03MH076381-01 | Screening | 7 | 3 | Completed |
| 7 | 699 | Secondary Calcium Response Assay for Formylpeptide Receptor (FPR) Antagonists | 1R03MH076381-01 | Screening | 34 | 16 | Completed |
| 8 | 722 | Formylpeptide Receptor (FPR) Ligand Structure Activity Relationship (SAR) Analysis : Primary HTS Assay | 1R03MH076381-01 | Screening | 1276 | 38 | Completed |
| 9 | 723 | Formylpeptide Receptor (FPR) Ligand Structure Activity Relationship (SAR) Analysis : Dose Response Assay Counterscreen Against Formyl Peptide Receptor-Like-1 (FPRL1) | 1R03MH076381-01 | Confirmatory | 58 | 0 | Completed |
| 10 | 724 | Formylpeptide Receptor (FPR) Ligand Structure Activity Relationship (SAR) Analysis : Dose Response Assay | 1R03MH076381-01 | Confirmatory | 58 | 15 | Completed |
| 11 | 725 | Formylpeptide Receptor (FPR) Ligand Structure Activity Relationship (SAR) Analysis : Primary HTS Assay Counterscreen Against Formyl Peptide Receptor-Like-1 (FPRL1) | 1R03MH076381-01 | Screening | 1276 | 1 | Completed |
| 12 | 762 | Formylpeptide Receptor (FPRL1) Ligand Structure Activity Relationship (SAR) Analysis : FPR Dose Response Counterscreen Assay | 1R03MH076381-01 | Confirmatory | 15 | 0 | Completed |
| 13 | 763 | Formylpeptide Receptor-Like-1 (FPRL1) Ligand Structure Activity Relationship (SAR) Analysis : FPR Primary HTS Assay Counterscreen | 1R03MH076381-01 | Screening | 170 | 1 | Completed |
| 14 | 765 | Formylpeptide Receptor-Like-1 (FPRL1) Ligand Structure Activity Relationship (SAR) Analysis : Primary HTS Assay | 1R03MH076381-01 | Screening | 170 | 3 | Completed |
| 15 | 766 | Formylpeptide Receptor (FPRL1) Ligand Structure Activity Relationship (SAR) Analysis : Dose Response Assay | 1R03MH076381-01 | Confirmatory | 15 | 5 | Completed |
| 16 | 805 | Assay for Formylpeptide Receptor Family Ligands: Target Formylpeptide Receptor | 1R03MH076381-01 | Summary | 15 | 15 | Completed |
| 17 | 863 | Formylpeptide Receptor (FPR) Structure Activity Relationship (SAR) Analysis: Secondary Calcium Response Assay for Antagonists | 1R03MH076381-01 | Other | 15 | 9 | Completed |
| 18 | 1061 | Formylpeptide Receptor-Like-1(FPRL1) Structure Activity Relationship (SAR) Analysis: Secondary Calcium Response Assay for Antagonists | 1R03MH076381-01 | Screening | 6 | 3 | Completed |
| 19 | 1202 | Assay for Formylpeptide Receptor Family Ligands: Target Formylpeptide Receptor-Like-1 | 1R03MH076381-01 | Summary | 6 | 6 | Completed |
| 20 | 757 | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype | 1RO3MH081231-01 | Screening | 194655 | 521 | Completed |
| 21 | 758 | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype | 1RO3MH081231-01 | Screening | 194659 | 107 | Completed |
| 22 | 759 | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | 1RO3MH081231-01 | Screening | 194653 | 267 | Completed |
| 23 | 760 | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype | 1RO3MH081231-01 | Screening | 194656 | 365 | Completed |
| 24 | 761 | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype | 1RO3MH081231-01 | Screening | 194656 | 398 | Completed |
| 25 | 764 | HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant | 1RO3MH081231-01 | Screening | 194653 | 219 | Completed |
| 26 | 751 | Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent) | 1X01MH077613-01 | Screening | 23718 | 39 | Completed |
| 27 | 1062 | Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent): Dose Response Assay | 1X01MH077613-01 | Confirmatory | 21 | 2 | Completed |
| 28 | 1207 | Flow Cytometric GFP Protein Degradation Assay: Secondary Assay for disassembly of the 26S Proteasome | 1X01MH077613-01 | Screening | 3 | 1 | Completed |
| 29 | 1210 | Estrogen Receptor (beta) binding: Primary Screen | 1X01MH077627-01 | Screening | 822 | 58 | Completed |
| 30 | 1211 | Estrogen Receptor (alpha) binding: Primary Screen | 1X01MH077627-01 | Screening | 822 | 71 | Completed |
| 31 | 1212 | GPR 30 Binding: Primary Screen | 1X01MH077627-01 | Screening | 151 | 15 | Completed |
| 32 | 1213 | CALCIUM_SIGNALING_VIA_GPR30: Primary Screen | 1X01MH077627-01 | Screening | 99 | 22 | Completed |
| 33 | 1218 | Functional assay for estrogen-mediated translocation of PIP3: Secondary Assay for Estrogen receptor beta | 1X01MH077627-01 | Screening | 12 | 3 | Completed |
| 34 | 1219 | Functional assay to assess estrogen-mediated translocation of PIP3: Secondary Assay for GPR30 estrogen receptor | 1X01MH077627-01 | Screening | 12 | 3 | Completed |
| 35 | 1221 | Estrogen Receptor (beta) binding: Dose Response of Primary Screen Assay | 1X01MH077627-01 | Confirmatory | 63 | 14 | Completed |
| 36 | 1223 | Estrogen Receptor (alpha) binding: Dose Response of Primary Screen Assay | 1X01MH077627-01 | Confirmatory | 63 | 17 | Completed |
| 37 | 1224 | GPR 30 Binding: Dose Response | 1X01MH077627-01 | Confirmatory | 10 | 3 | Completed |
| 38 | 1226 | Functional assay for estrogen-mediated translocation of PIP3: Secondary Assay for Estrogen receptor alpha | 1X01MH077627-01 | Screening | 12 | 4 | Completed |
| 39 | 528 | Allosteric Agonists for the VLA-4 Integrin | 1X01MH077638-01 | Screening | 23786 | 2 | Completed |
| 40 | 529 | Allosteric Antagonists for the VLA-4 Integrin | 1X01MH077638-01 | Screening | 23786 | 48 | Completed |
| 41 | 576 | Auto-fluorescence of compounds effecting screening of VLA-4 Integrin | 1X01MH077638-01 | Other | 23785 | 146 | Completed |
| 42 | 702 | Dose-Response of Allosteric Antagonists for the VLA-4 Integrin | 1X01MH077638-01 | Confirmatory | 62 | 34 | Completed |
| 43 | 703 | Dose-Response of Allosteric Agonists for the VLA-4 Integrin | 1X01MH077638-01 | Confirmatory | 5 | 0 | Completed |
| 44 | 795 | MLSCN Assay for Activators of Prostate Cell Differentiation | 1X01MH078937-01 | Screening | 23718 | 134 | Completed |
| 45 | 1069 | MLSCN Assay for Activators of Prostate Cell Differentiation: Single point confirmation of side scatter shift | 1X01MH078937-01 | Screening | 430 | 50 | Completed |
| 46 | 1076 | MLSCN Assay for Activators of Prostate Cell Differentiation: Single point confirmation of potential cell killers | 1X01MH078937-01 | Other | 430 | 29 | Completed |
| 47 | 1196 | MLSCN Assay for Activators of Prostate Cell Differentiation: Secondary Dose Response Assay | 1X01MH078937-01 | Confirmatory | 95 | 35 | Completed |
| 48 | 1197 | MLSCN Assay for Activators of Prostate Cell Differentiation: Primary Screen Dose Response of Potential Cell Killers | 1X01MH078937-01 | Confirmatory | 95 | 19 | Completed |
| 49 | 1198 | MLSCN Assay for Activators of Prostate Cell Differentiation: Primary Dose Response Assay | 1X01MH078937-01 | Confirmatory | 95 | 29 | Completed |
| 50 | 1200 | MLSCN Assay for Activators of Prostate Cell Differentiation: Counter Screen Dose Response of Potential Cell Killers | 1X01MH078937-01 | Confirmatory | 95 | 37 | Completed |
| 51 | 527 | Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing | 1X01MH078952-01 | Screening | 24085 | 64 | Completed |
| 52 | 700 | Dose Response Assay for Inhibitors of Bacterial Quorum Sensing | 1X01MH078952-01 | Confirmatory | 94 | 19 | Completed |
| 53 | 1014 | Inhibitors of Bacterial Quorum Sensing Structure Activity Relationship (SAR) Analysis: Primary HTS Assay | 1X01MH078952-01 | Screening | 240 | 26 | Completed |
| 54 | 1015 | Inhibitors of Bacterial Quorum Sensing Structure Activity Relationship (SAR) Analysis: Dose Response Assay | 1X01MH078952-01 | Confirmatory | 32 | 32 | Completed |
| 55 | 1206 | Inhibitors of Bacterial Quorum Sensing: Summary | 1X01MH078952-01 | Summary | 45 | 45 | Completed |
| 56 | 950 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2 | 1X01MH079850-01 | Screening | 134474 | 104 | In progress |
| 57 | 951 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B | 1X01MH079850-01 | Screening | 134474 | 133 | In progress |
| 58 | 952 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W | 1X01MH079850-01 | Screening | 134474 | 28 | In progress |
| 59 | 1007 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL | 1X01MH079850-01 | Screening | 134474 | 69 | In progress |
| 60 | 1008 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1 | 1X01MH079850-01 | Screening | 134474 | 179 | In progress |
| 61 | 1009 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 | 1X01MH079850-01 | Screening | 134474 | 154 | In progress |